Allergan Catalysts Drive Expansion and 4 Stock Analyses to Know Now
Allergan Inc. (NYSE:AGN): Current price $42.45
After rolling their valuation out to 2014, Susquehanna raised their price target for Allergan Inc. shares and keeps an Outperform rating on the name. Susquehanna expects Allergan to be a much better performer in 2013 after underperforming the specialty pharma group in 2012. The firm believes that pipeline catalysts could support multiple expansion in 2013.